Hannes Vogel

Clinical Focus

• Pathology and Laboratory Medicine
• Anatomic/Clinical Pathology

Administrative Appointments

• Associate Chair for Neuropathology, Department of Pathology , (2005– present )
• Voting member, Panel 4, Stanford IRB , (2002– 2007 )

Honors and Awards

• Award for Excellence in Preclinical Teaching, Henry J. Kaiser Family Foundation (June 11, 2005)

Professional Education

• Board Certification: Anatomic Pathology, American Board of Pathology (1989)
• Board Certification: Neuropathology, American Board of Pathology (1989)
• Texas Childrens Hospital (2001) TX
• SUMC - Graduate Medical Education (1989) CA
• Beth Israel Deaconess Medical Center, Harvard Medical School (1987) MA
• Board Certification: Pediatrics, American Board of Pediatrics (1986)
• UCSF Medical Center (1984) CA
• Baylor College of Medicine (1982) TX
• Baylor College of Medicine (1981) TX
• Baylor College of Medicine (1980) TX
• BA, Rice University Biology (1975)
• MD, Baylor College of Medicine (1980)

Community & International Work

• Baltic Association of Neuropathology, Latvia, Lithuania, Estonia More »

Web Site Links

• Pathology website listing

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. 

• Consulting: Burns, White & Hickton, Civerolo, Gralow, Hill & Curtis P.A., Jeffrey S. Pop & Associates

Research Interests

My research interests include nerve and muscle pathology, mitochondrial diseases, pediatric neurooncology, and transgenic mouse pathology.

Publications

• A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy. Mobley BC,  Enns GM, Wong LJ, Vogel H.  Clin Neuropathol.  2009 Mar-Apr; 28 (2): 143-9
• Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation. Sangoi AR,  Dulai MS, Beck AH, Brat DJ, Vogel H.  Am J Surg Pathol.  2009; 33 (5): 669-81
• Timing of Bone Marrow Cell Delivery Has Minimal Effects on Cell Viability and Cardiac Recovery Following Myocardial Infarction. Swijnenburg RJ,  Govaert JA, van der Bogt KE, Pearl JI, Huang M, Stein W, Hoyt G, Vogel H, Contag CH, Robbins RC, Wu JC.  Circ Cardiovasc Imaging.  2009;
• Breast cancer brain metastases express the sodium iodide symporter. Renier C,  Vogel H, Offor O, Yao C, Wapnir I.  J Neurooncol.  2009;
• Papillary tumor of the spinal cord: report of 2 cases. Mobley B,  Kalani MY, Harsh GR, Edwards MS, Vogel H.  Am J Surg Pathol.  2009; 33 (8): 1191-7
• The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. Gratzinger D,  Zhao S, West R, Rouse RV, Vogel H, Gil EC, Levy R, Lossos IS, Natkunam Y.  Am J Clin Pathol.  2009; 131 (2): 264-78
• Drosophila models of neurodegenerative diseases. Lu B,  Vogel H.  Annu Rev Pathol.  2009; 4 315-42
• Intraventricular metaplastic meningioma in a child: case report and review of the literature. Dulai MS,  Khan AM, Edwards MS, Vogel H.  Neuropathology.  2009;
• Intracerebral hemorrhage caused by cerebral amyloid angiopathy in a 53-year-old man. Campbell DM,  Bruins S, Vogel H, Shuer LM, Wijman CA.  J Neurol.  2008; 255 (4): 597-8
• CNS T-cell lymphoma: an under-recognized entity? Dulai MS,  Park CY, Howell WD, Smyth LT, Desai M, Carter DM, Vogel H.  Acta Neuropathol.  2008; 115 (3): 345-56
• Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Yang Y,  Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, Lu B.  Proc Natl Acad Sci U S A.  2008; 105 (19): 7070-5
• Severe congenital encephalopathy caused by MECP2 null mutations in males: central hypoxia and reduced neuronal dendritic structure. Schüle B,  Armstrong DD, Vogel H, Oviedo A, Francke U.  Clin Genet.  2008; 74 (2): 116-26
• Suprasellar giant cell ependymoma: a rare neoplasm in a unique location. Sangoi AR,  Lim M, Dulai M, Vogel H, Chang S.  Hum Pathol.  2008; 39 (9): 1396-401
• Congenital glioblastoma multiforme: case report and review of the literature. Hou LC,  Bababeygy SR, Sarkissian V, Fisher PG, Vogel H, Barnes P, Huhn SL.  Pediatr Neurosurg.  2008; 44 (4): 304-12
• CHD5 is a tumor suppressor at human 1p36. Bagchi A,  Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, Bredel M, Vogel H, Mills AA.  Cell.  2007; 128 (3): 459-75
• Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. Hsu AR,  Cai W, Veeravagu A, Mohamedali KA, Chen K, Kim S, Vogel H, Hou LC, Tse V, Rosenblum MG, Chen X.  J Nucl Med.  2007; 48 (3): 445-54
• A 35-year-old woman with a dural-based mass. Haddix T,  Chang S, Vogel H.  Brain Pathol.  2007; 17 (3): 331-2
• In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model. Hsu AR,  Hou LC, Veeravagu A, Greve JM, Vogel H, Tse V, Chen X.  Mol Imaging Biol.  2006 Nov-Dec; 8 (6): 315-23
• Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Yang Y,  Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, Lu B.  Proc Natl Acad Sci U S A.  2006; 103 (28): 10793-8
• Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. Jang T,  Savarese T, Low HP, Kim S, Vogel H, Lapointe D, Duong T, Litofsky NS, Weimann JM, Ross AH, Recht L.  Am J Pathol.  2006; 168 (5): 1676-85
• Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Ding J,  Allen E, Wang W, Valle A, Wu C, Nardine T, Cui B, Yi J, Taylor A, Jeon NL, Chu S, So Y, Vogel H, Tolwani R, Mobley W, Yang Y.  Hum Mol Genet.  2006; 15 (9): 1451-63
• Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. Bredel M,  Bredel C, Juric D, Duran GE, Yu RX, Harsh GR, Vogel H, Recht LD, Scheck AC, Sikic BI.  J Clin Oncol.  2006; 24 (2): 274-87
• Transcriptional profiling of aging in human muscle reveals a common aging signature. Zahn JM,  Sonu R, Vogel H, Crane E, Mazan-Mamczarz K, Rabkin R, Davis RW, Becker KG, Owen AB, Kim SK.  PLoS Genet.  2006; 2 (7): e115
• alpha(v)beta(3) Integrin in central nervous system tumors. Lim M,  Guccione S, Haddix T, Sims L, Cheshier S, Chu P, Vogel H, Harsh G.  Hum Pathol.  2005; 36 (6): 665-9
• Identification of phenotypic neural stem cells in a pediatric astroblastoma. Huhn SL,  Yung Y, Cheshier S, Harsh G, Ailles L, Weissman I, Vogel H, Tse V.  J Neurosurg.  2005; 103 (5 Suppl): 446-50
• Gigaxonin interacts with tubulin folding cofactor B and controls its degradation through the ubiquitin-proteasome pathway. Wang W,  Ding J, Allen E, Zhu P, Zhang L, Vogel H, Yang Y.  Curr Biol.  2005; 15 (22): 2050-5
• Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Bredel M,  Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI.  Cancer Res.  2005; 65 (19): 8679-89
• Characterization of the integrin alpha v beta3 in arteriovenous malformations and cavernous malformations. Lim M,  Haddix T, Harsh GR, Vogel H, Steinberg GK, Guccione S.  Cerebrovasc Dis.  2005; 20 (1): 23-7
• NF90 regulates cell cycle exit and terminal myogenic differentiation by direct binding to the 3'-untranslated region of MyoD and p21WAF1/CIP1 mRNAs. Shi L,  Zhao G, Qiu D, Godfrey WR, Vogel H, Rando TA, Hu H, Kao PN.  J Biol Chem.  2005; 280 (19): 18981-9
• High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Bredel M,  Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI.  Cancer Res.  2005; 65 (10): 4088-96
• p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Keyes WM,  Wu Y, Vogel H, Guo X, Lowe SW, Mills AA.  Genes Dev.  2005; 19 (17): 1986-99
• Diagnostic immunohistology of muscle diseases. Vogel H,  Zamecnik J.  J Neuropathol Exp Neurol.  2005; 64 (3): 181-93
• Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. Bredel M,  Bredel C, Juric D, Kim Y, Vogel H, Harsh GR, Recht LD, Pollack JR, Sikic BI.  J Mol Diagn.  2005; 7 (2): 171-82
• Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutations. Grogan PM,  Tanner SM, Ørstavik KH, Knudsen GP, Saperstein DS, Vogel H, Barohn RJ, Herbelin LL, McVey AL, Katz JS.  Neurology.  2005; 64 (9): 1638-40
• Hematopoietic cells maintain hematopoietic fates upon entering the brain. Massengale M,  Wagers AJ, Vogel H, Weissman IL.  J Exp Med.  2005; 201 (10): 1579-89
• Burden of proof in the postmortem diagnosis of mitochondrial disease: Leigh disease. Vogel H,  Pediatr Dev Pathol.  2004 Nov-Dec; 7 (6): 615-9
• Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems. Vogel H,  Fuller GN.  Ann Diagn Pathol.  2003; 7 (6): 387-98